Literature DB >> 28328132

Revised estimates of the risk of fetal loss following a prenatal diagnosis of trisomy 13 or trisomy 18.

Alana Cavadino1, Joan K Morris1.   

Abstract

Edwards syndrome (trisomy 18) and Patau syndrome (trisomy 13) both have high natural fetal loss rates. The aim of this study was to provide estimates of these fetal loss rates by single gestational week of age using data from the National Down Syndrome Cytogenetic Register. Data from all pregnancies with Edwards or Patau syndrome that were prenatally detected in England and Wales from 2004 to 2014 was analyzed using Kaplan-Meier survival estimates. Pregnancies were entered into the analysis at the time of gestation at diagnosis, and were considered "under observation" until the gestation at outcome. There were 4088 prenatal diagnoses of trisomy 18 and 1471 of trisomy 13 in the analysis. For trisomy 18, 30% (95%CI: 25-34%) of viable fetuses at 12 weeks will result in a live birth and at 39 weeks gestation 67% (60-73%) will result in a live birth. For trisomy 13 the survival is 50% (41-58%) at 12 weeks and 84% (73-90%) at 39 weeks. There was no significant difference in survival between males and females when diagnosed at 12 weeks for trisomy 18 (P-value = 0.27) or trisomy 13 (P-value = 0.47). This paper provides the most precise gestational age-specific estimates currently available for the risk of fetal loss in trisomy 13 and trisomy 18 pregnancies in a general population.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  fetal loss; trisomy 13; trisomy 18

Mesh:

Year:  2017        PMID: 28328132     DOI: 10.1002/ajmg.a.38123

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  4 in total

1.  A visual tool inclusive of fetal ultrasound and autopsy findings to reach a balanced approach to counseling on trisomy 18 in early second trimester.

Authors:  Stefania Triunfo; Marta Bonollo; Priska Gaffuri; Manuela Viviano; Daniele Satta; Manuela Bergmann
Journal:  Arch Gynecol Obstet       Date:  2021-06-22       Impact factor: 2.344

2.  Establishment of a human trisomy 18 induced pluripotent stem cell line from amniotic fluid cells.

Authors:  Kaixuan Xing; Yazhou Cui; Jing Luan; Xiaoyan Zhou; Liang Shi; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2018-05

3.  Knowledge and attitude of pregnant women in the Kingdom of Saudi Arabia toward Noninvasive prenatal testing: A single center study.

Authors:  Maaged A Akiel; Mohamud S Mohamud; Emad M Masuadi; Hassan S Alamri
Journal:  Mol Genet Genomic Med       Date:  2022-04-28       Impact factor: 2.473

4.  Single-Cell Transcriptomics of Cultured Amniotic Fluid Cells Reveals Complex Gene Expression Alterations in Human Fetuses With Trisomy 18.

Authors:  Jing Wang; Zixi Chen; Fei He; Trevor Lee; Wenjie Cai; Wanhua Chen; Nan Miao; Zhiwei Zeng; Ghulam Hussain; Qingwei Yang; Qiwei Guo; Tao Sun
Journal:  Front Cell Dev Biol       Date:  2022-03-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.